Penumbra (PEN) Short-term Investments (2014 - 2026)
Penumbra's (PEN) quarterly Short-term Investments came in at $374.4 million in Q1 2026, up 13299.11% year-on-year from N/an in Q1 2025, and up 4.6% on a QoQ basis from $357.9 million in Q4 2025.
Penumbra (PEN) Short-term Investments (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Short-term Investments data on file, last reported at $374.4 million in Q1 2026.
- On a quarterly basis, Short-term Investments rose 13299.11% year-over-year to $374.4 million in Q1 2026; TTM through Mar 2026 was $374.4 million, a 13299.11% increase from a year earlier, with the FY2025 full-year figure at $357.9 million, up 2175.83% from the prior year.
- Short-term Investments for Q1 2026 stood at $374.4 million, up from $357.9 million in the prior quarter.
- Over the last five years, Short-term Investments for PEN reached as high as $374.4 million in Q1 2026 and fell as low as $2.8 million in Q1 2025.
- Historically, Short-term Investments has averaged $123.7 million across 5 years, with a median of $118.2 million in 2022.
- Across the five-year window, Short-term Investments sank 96.91% in 2025 and surged 13299.11% in 2026, its largest moves.
- Year by year, Short-term Investments stood at $118.2 million in 2022, then rose by 2.99% to $121.7 million in 2023, then slumped by 87.08% to $15.7 million in 2024, then surged by 2175.83% to $357.9 million in 2025, then rose by 4.6% to $374.4 million in 2026.
- Per Business Quant data, the three most recent Short-term Investments figures were $374.4 million in Q1 2026, $357.9 million in Q4 2025, and $149.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 374.37 Mn |
| Dec 31, 2025 | 357.92 Mn |
| Sep 30, 2025 | 149.27 Mn |
| Jun 30, 2025 | 2.80 Mn |
| Mar 31, 2025 | 2.79 Mn |
| Dec 31, 2024 | 15.73 Mn |
| Sep 30, 2024 | 10.55 Mn |
| Jun 30, 2024 | 51.36 Mn |
| Mar 31, 2024 | 90.36 Mn |
| Dec 31, 2023 | 121.70 Mn |
| Sep 30, 2023 | 148.10 Mn |
| Jun 30, 2023 | 106.90 Mn |
| Mar 31, 2023 | 104.41 Mn |
| Dec 31, 2022 | 118.17 Mn |
| Sep 30, 2022 | 129.58 Mn |
| Jun 30, 2022 | 146.14 Mn |
| Mar 31, 2022 | 172.18 Mn |
| Dec 31, 2021 | 195.50 Mn |
| Sep 30, 2021 | 200.64 Mn |
| Jun 30, 2021 | 156.72 Mn |